Related Experiment Videos
Light-induced anticancer activity of [RuCl2(DMSO)4] complexes.
Małgorzata Brindell1, Ewa Kuliś, Sofi K C Elmroth
1Department of Inorganic Chemistry, Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Krakow, Poland.
Journal of Medicinal Chemistry
|November 11, 2005
Summary
Ruthenium(II) complexes, trans-[RuCl2(DMSO)4] and cis-[RuCl2(DMSO)4], show enhanced anticancer activity against melanoma cells when exposed to UVA light. Photochemical reactions with DNA models reveal light facilitates ruthenium-DNA adduct formation.
Area of Science:
- Inorganic Chemistry
- Photochemistry
- Cancer Research
Background:
- Ruthenium complexes are investigated for their potential therapeutic applications, particularly in cancer treatment.
- Understanding the photophysical and photochemical properties of ruthenium complexes is crucial for developing photodynamic therapies.
Purpose of the Study:
- To evaluate the cytotoxicity and photocytotoxicity of trans- and cis-[RuCl2(DMSO)4] complexes in melanoma cell lines.
- To investigate the photochemical reactivity of these ruthenium(II) complexes with a DNA model oligonucleotide.
Main Methods:
- Cytotoxicity assays were performed on human (SK-MEL 188) and mouse (S91) melanoma cell lines.
- Photocytotoxicity was assessed after UVA irradiation.
- Chromatography and mass spectrometry were used to study the reaction of ruthenium complexes with the oligonucleotide d(T2GGT2).
Main Results:
- The trans isomer exhibited higher cytotoxicity than the cis isomer, both in the dark and under illumination.
- Antiproliferative activity of both isomers was significantly enhanced upon UVA irradiation.
- Photochemical reactions led to the formation of Ru(G-N7)2 adducts with the oligonucleotide, a process accelerated by light, especially for the cis isomer.
Conclusions:
- Ruthenium(II) complexes demonstrate significant photocytotoxic effects against melanoma cells.
- UVA irradiation enhances the antiproliferative activity of these complexes.
- Photochemical activation facilitates the formation of ruthenium-DNA adducts, suggesting a potential mechanism for their therapeutic action.